| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | York Zöllner | |
| Khaled Maman | |||
| Gerard Duru | |||
| Donato Greco | |||
| Vanessa Remy | |||
| Semukaya Sendyona | |||
| P2860 | cites work | Needle-stick injuries in the National Health Service: a culture of silence | Q28269720 |
| Parental compliance with multiple immunization injections | Q33790782 | ||
| Improving immunisation coverage in rural India: clustered randomised controlled evaluation of immunisation campaigns with and without incentives | Q33857269 | ||
| Measles outbreak in a highly vaccinated population, San Diego, 2008: role of the intentionally undervaccinated | Q34105917 | ||
| Rethinking the benefits and costs of childhood vaccination: the example of the Haemophilus influenzae type b vaccine | Q34155024 | ||
| The global value of vaccination | Q34171002 | ||
| Contagious diseases in the United States from 1888 to the present. | Q34246143 | ||
| Strategies for development of combination vaccines | Q34435395 | ||
| Safety of combination vaccines: perception versus reality | Q34435433 | ||
| Combination vaccines: defining and addressing current safety concerns | Q34440127 | ||
| Evaluating the safety of combination vaccines | Q34440135 | ||
| Manufacturing issues related to combining different antigens: an industry perspective | Q34440161 | ||
| Combination vaccines: choices or chaos? A practitioner's perspective | Q34440194 | ||
| Vaccine refusal, mandatory immunization, and the risks of vaccine-preventable diseases | Q34979528 | ||
| Benefits of combination vaccines: effective vaccination on a simplified schedule. | Q35058872 | ||
| Communicating the benefits of combination vaccines to parents and health care providers | Q35094821 | ||
| Pediatric combination vaccines: their impact on patients, providers, managed care organizations, and manufacturers | Q35110617 | ||
| Vaccination recommendations for Germany | Q35591138 | ||
| A liquid hexavalent combined vaccine against diphtheria, tetanus, pertussis, poliomyelitis, Haemophilus influenzae type B and hepatitis B: review of immunogenicity and safety | Q35737846 | ||
| Drug versus vaccine investment: a modelled comparison of economic incentives | Q37355939 | ||
| DTPa-HBV-IPV/Hib Vaccine (Infanrix hexa): A Review of its Use as Primary and Booster Vaccination | Q37756125 | ||
| A DTaP-IPV//PRP∼T vaccine (Pentaxim): a review of 16 years' clinical experience | Q37900296 | ||
| DTaP-IPV-Hep B-Hib vaccine (Hexaxim®) : a review of its use in primary and booster vaccination | Q38075844 | ||
| Multiple immunizations. Ouch! | Q39388863 | ||
| Immunization practices of pediatricians and family physicians in the United States. | Q39389587 | ||
| Use of combination vaccines is associated with improved coverage rates | Q39798690 | ||
| Societal impact of combination vaccines: experiences of physicians, nurses, and parents | Q40052706 | ||
| Combined and simultaneously administered vaccines. A brief history. | Q40454280 | ||
| The hidden costs of infant vaccination | Q40617147 | ||
| European Commission COST/STD Initiative. Report of the expert panel VIII. New vaccines, especially new combined vaccines | Q41107555 | ||
| Would better adherence to guidelines improve childhood immunization rates? | Q41252315 | ||
| Improving childhood vaccination rates | Q44650594 | ||
| Local health department costs associated with response to a school-based pertussis outbreak --- Omaha, Nebraska, September-November 2008. | Q44839035 | ||
| DTPa-HBV-IPV/Hib vaccine (Infanrix hexa™): a guide to its use in infants. | Q46008302 | ||
| Health and economic consequences of an outbreak of pertussis among healthcare workers in a hospital in France | Q46408988 | ||
| Qualitative analysis of mothers' decision-making about vaccines for infants: the importance of trust | Q46909897 | ||
| The effect of additional shots on the vaccine administration process: results of a time-motion study in 2 settings. | Q50506971 | ||
| Preventing needlestick injuries among healthcare workers: a WHO-ICN collaboration. | Q51542209 | ||
| Nosocomial pertussis: costs of an outbreak and benefits of vaccinating health care workers. | Q52569035 | ||
| Measles outbreak associated with an international youth sporting event in the United States, 2007. | Q54431975 | ||
| Underimmunization among children: effects of vaccine safety concerns on immunization status | Q64133393 | ||
| Standards for pediatric immunization practices. Ad Hoc Working Group for the Development of Standards for Pediatric Immunization Practices | Q70626446 | ||
| Physician and parent opinions. Are children becoming pincushions from immunizations? | Q71953576 | ||
| Too many shots? Parent, nurse, and physician attitudes toward multiple simultaneous childhood vaccinations | Q72705037 | ||
| [Immunization: leaps into the future. Combined vaccines (II)] | Q73471764 | ||
| Comparison of the reactogenicity and immunogenicity of a combined diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated polio (DTPa-HBV-IPV) vaccine, mixed with the Haemophilus influenzae type b (Hib) conjugate vaccine and administered | Q73816602 | ||
| Comparison of parental and health care professional preferences for the acellular or whole cell pertussis vaccine | Q74287633 | ||
| Medicine. The intangible value of vaccination | Q74593158 | ||
| Economic value to parents of reducing the pain and emotional distress of childhood vaccine injections | Q77158443 | ||
| Prelicensure evaluation of combination vaccines | Q77175320 | ||
| Considerations for implementing a new combination vaccine into managed care | Q78878870 | ||
| [Hexavalent combined vaccination] | Q80935144 | ||
| Impact of a pentavalent combination vaccine on immunization timeliness in a state Medicaid population | Q83195100 | ||
| The use of combination vaccines has improved timeliness of vaccination in children | Q83863803 | ||
| Long-term solutions for the problem of vaccine shortages | Q94372250 | ||
| P433 | issue | 9 | |
| P304 | page(s) | 2132-2141 | |
| P577 | publication date | 2015-06-15 | |
| P1433 | published in | Human Vaccines & Immunotherapeutics | Q21072749 |
| P1476 | title | The value of childhood combination vaccines: From beliefs to evidence | |
| P478 | volume | 11 |
| Q38391478 | A Phase III randomized, double-blind, clinical trial of an investigational hexavalent vaccine given at 2, 4, and 11-12 months |
| Q38532558 | Assessment of preparation time with fully-liquid versus non-fully liquid paediatric hexavalent vaccines. A time and motion study |
| Q38383640 | Concomitant administration of a fully liquid, ready-to-use DTaP-IPV-HB-PRP-T hexavalent vaccine with a meningococcal serogroup C conjugate vaccine in infants |
| Q90564961 | Effect of Aluminum Adjuvant and Preservatives on Structural Integrity and Physicochemical Stability Profiles of Three Recombinant Subunit Rotavirus Vaccine Antigens |
| Q56380558 | Hexavalent vaccines: characteristics of available products and practical considerations from a panel of Italian experts |
| Q47553281 | Immunization of preterm infants with GSK's hexavalent combined diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine: A review of safety and immunogenicity |
| Q93172310 | Immunogenicity and safety following primary and booster vaccination with a hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus and Haemophilus influenzae type b vaccine: a randomized trial in the United States |
| Q89673481 | Immunogenicity and safety of a combined DTPa-IPV/Hib vaccine administered as a three-dose primary vaccination course and a booster dose in healthy children in Russia: a phase III, non-randomized, open-label study |
| Q92089113 | Immunogenicity and safety of a liquid Pentavalent (DTwP-Hb-Hib) combination vaccine manufactured by Human Biologicals Institute in 6-8 weeks old healthy infants: A phase III, randomized, single blind, non-inferiority study |
| Q40184580 | Immunogenicity and safety of a new hexavalent vaccine (DTaP5-IPV-HB-Hib) administered in a mixed primary series schedule with a pentavalent vaccine (DTaP5-IPV-Hib). |
| Q40063992 | Immunogenicity and safety of primary and booster vaccination with 2 investigational formulations of diphtheria, tetanus and Haemophilus influenzae type b antigens in a hexavalent DTPa-HBV-IPV/Hib combination vaccine in comparison with the licensed I |
| Q38788650 | Mothers' preferences regarding new combination vaccines for their children in Japan, 2014. |
| Q39414010 | New perspectives for hexavalent vaccines. |
| Q90469720 | Sex differences in vaccine-induced humoral immunity |
| Q90020413 | Use of different combination diphtheria-tetanus-acellular pertussis vaccines does not increase risk of 30-day infant mortality. A population-based linkage cohort study using administrative data from the Australian Childhood Immunisation Register and |
| Q47107649 | Vaccination coverage and immunization timeliness among children aged 12-23 months in Senegal: a Kaplan-Meier and Cox regression analysis approach |
| Q42101765 | Vaccine development for syphilis. |
| Q91782447 | Valuing the cost of improving Chilean primary vaccination: a cost minimization analysis of a hexavalent vaccine |
| Q39394364 | Varicella vaccination - the global experience |
Search more.